Capricor Therapeutics, Inc.
CAPR
Revenue
3.97M
▼-935.44k▼-19.06%
3 Months ChangeAssets
38.28M
▼-11.17M▼-22.58%
3 Months ChangeLiabilities
26.78M
▼-4.23M▼-13.66%
3 Months ChangeFree Cash Flow
-1.88M
▼-5.74M▼-148.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001558370-24-013357
2024-10-16
Form 8-K
ID: 0001558370-24-013344
2024-10-09
Form 8-K
ID: 0001558370-24-013207
2024-09-24
Form 8-K
ID: 0001558370-24-012983
2024-09-17
Form 8-K
ID: 0001558370-24-012836
2024-08-08
Form 10-Q
ID: 0001558370-24-011638
2024-08-07
Form 8-K
ID: 0001558370-24-011350
2024-05-15
Form 8-K
ID: 0001558370-24-008313
2024-05-15
Form 8-K
ID: 0001558370-24-008310
2024-05-14
Form 10-Q
ID: 0001558370-24-008072